Literature DB >> 35422950

Clinical efficacy of turtle shell decocted pills for endometriosis and their influence on cellular immunity.

Yunfang Wu1,2, Jichen Zhang3, Ting Wang4, Kai Lou5.   

Abstract

OBJECTIVE: To explore the therapeutic efficacy of the levonorgestrel-releasing intrauterine system combined with turtle shell decocted pills for endometriosis and their effect on cellular immune function.
METHODS: Clinical data of 118 patients with endometriosis admitted to Taizhou First People's Hospital from January 2019 to January 2020 were retrospectively analyzed. The patients were assigned into a single-drug group (n=68) and a combined traditional Chinese medicine group (n=50) according to treatment methods. The single-drug group was treated with the levonorgestrel-releasing intrauterine system, and the combined traditional Chinese medicine group was treated with additional turtle shell decocted pills for three cycles for a total of 12 weeks. Enzyme-linked immunosorbent assay was adopted to measure the concentration of Th1 cytokines (tumor necrosis factor (TNF)-α and interferon (IFN)-γ) and Th2 cytokines (interleukin (IL)-6 and IL-10), and the protein level of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1). The levels of serum luteinizing hormone (LH), follicle stimulating hormone (FSH), and estradiol (E2) were compared between the two groups. The response rate of treatment, the control rate of blood pressure and the incidence of adverse reactions were recorded in both groups.
RESULTS: The response rate of treatment in the combined traditional Chinese medicine group was higher than that in the single-drug group (P<0.05). Compared to before treatment, the TNF-α and IFN-γ increased in both groups after treatment, and the expressions were higher in the combined traditional Chinese medicine group than in the single-drug group (all P<0.05). After treatment, the levels of IL-6, IL-10, PD-1, and PD-L1 decreased, and the decreases in the combined traditional Chinese medicine group were greater than those in the single-drug group (all P<0.05). Serum LH, FSH and E2 levels before and after the treatment in the two groups were not statistically different (all P>0.05). The incidence of treatment-related adverse reactions between the two groups of patients was also not statistically different (P>0.05).
CONCLUSION: Turtle shell decocted pills can increase the clinical efficacy of levonorgestrel-releasing intrauterine system in the treatment of endometriosis, reduce levels of PD-1, and PD-L1 and improve cellular immune function. The pills do not affect the secretion of ovarian hormones or increase adverse reactions. AJTR
Copyright © 2022.

Entities:  

Keywords:  Endometriosis; cellular immunity; levonorgestrel-releasing intrauterine system; sex hormone; turtle shell decocted pills

Year:  2022        PMID: 35422950      PMCID: PMC8991112     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  27 in total

1.  The prognostic role of ovarian endometriosis in symptomatic adenomyosis patients underwent uterine artery embolization.

Authors:  Wenbo Guo; Siqi Hu; Dan Zeng; Chaogui Yan; Rui Zheng; Jian Gao; Tingting Wan; Wenquan Zhuang; Jianyong Yang
Journal:  Ann Palliat Med       Date:  2021-02-07

2.  Assessment of menstrual blood loss using a pictorial chart.

Authors:  J M Higham; P M O'Brien; R W Shaw
Journal:  Br J Obstet Gynaecol       Date:  1990-08

3.  Using social media to educate women and healthcare providers on endometriosis: preliminary results.

Authors:  Márcia Mendonça Carneiro; Barbara Lopes Farace; Luisa Silva de Carvalho Ribeiro; Raphaela Cristina Conrado C Silverio; Thais Moreira; Agnaldo Lopes da Silva Filho; Ana Luiza Lunardi Rocha Baroni; Márcia Cristina França Ferreira
Journal:  JBRA Assist Reprod       Date:  2020-01-30

Review 4.  Research progress of PD-1/PD-L1 immunotherapy in gastrointestinal tumors.

Authors:  Jiangang Sun; Yichao Zheng; Maa Mamun; Xiaojing Li; Xiaoping Chen; Yongshun Gao
Journal:  Biomed Pharmacother       Date:  2020-07-08       Impact factor: 6.529

5.  Evaluating the Efficacy of Levonorgestrel Intrauterine System and Danazol for Relief of Postoperative Pain in Endometriosis.

Authors:  Ashima Taneja; Satinder Kaur; R K Soni; Jaspreet Kaur; Laveen Singla
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 6.  Meta-Analysis of Chinese Traditional Medicine Bushen Huoxue Prescription for Endometriosis Treatment.

Authors:  Jing Shan; Wen Cheng; Dong-Xia Zhai; Dan-Ying Zhang; Rui-Pin Yao; Ling-Ling Bai; Zai-Long Cai; Yu-Huan Liu; Chao-Qin Yu
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-23       Impact factor: 2.629

7.  Comparative efficacy and safety of traditional Chinese patent medicine for endometriosis: A Bayesian network meta-analysis protocol.

Authors:  Shuangqian Dong; Jianwei Zhang; Fengting Zhai; Xinglong Zhao; Xiuyun Qin
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 8.  Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?

Authors:  Luciana Cacciottola; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 9.  Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?

Authors:  Ryan M Marquardt; Tae Hoon Kim; Jung-Ho Shin; Jae-Wook Jeong
Journal:  Int J Mol Sci       Date:  2019-08-05       Impact factor: 5.923

Review 10.  The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights.

Authors:  Antonio Simone Laganà; Simone Garzon; Martin Götte; Paola Viganò; Massimo Franchi; Fabio Ghezzi; Dan C Martin
Journal:  Int J Mol Sci       Date:  2019-11-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.